Exchange Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-17,536
Closed -$2.94M 153
2019
Q2
$2.94M Buy
17,536
+3,878
+28% +$537K 0.79% 50
2019
Q1
$2M Buy
13,658
+4,524
+50% +$656K 0.56% 67
2018
Q4
$1.22M Sell
9,134
-16,239
-64% -$2.66M 0.4% 79
2018
Q3
$4.83M Buy
25,373
+990
+4% +$182K 1.4% 22
2018
Q2
$4.07M Buy
24,383
+1,390
+6% +$223K 1.21% 26
2018
Q1
$3.87M Buy
+22,993
New +$3.86M 1.22% 26

Other funds holding AGN

Exchange Capital Management's AGN Position: Q3 2019 in Review

Exchange Capital Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 17,536 shares — an estimated $2.94M sold.

Exchange Capital Management first reported a position in AGN in Q1 2018 and held it in 6 quarters. The position peaked at $4.83M in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Exchange Capital Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Exchange Capital Management sold 17,536 Allergan plc shares in Q3 2019, an estimated $2.94M.
  • Exchange Capital Management first reported a position in Allergan plc in Q1 2018 and held it in 6 quarters.
  • Exchange Capital Management's Allergan plc position peaked at $4.83M in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Exchange Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.